Skip to main content

Table 3 Risk of second primary cancer after primary POFT cancer diagnosis according to histology

From: Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study

Histology Serous Mucinous Endometrioid Clear cell Transitional cell Carcinosarcoma
SIR CI SIR CI SIR CI SIR CI SIR CI SIR CI
Leukaemia 4.77# (2.83–7.54) 1.14 (0.14–4.11) 0.00 (0.00–3.95) 3.48 (0.42–12.58) 0.00 (0.00–37.27) 0.00 (0.00–127.79)
Urinary bladder 1.81 (0.59–4.22) 1.68 (0.20–6.06) 4.59 (0.95–13.43) 0.00 (0.00–11.77) 0.00 (0.00–51.86) 0.00 (0.00–128.39)
Lung, bronchus 1.08 (0.71–1.58) 3.59# (2.52–4.98) 1.54 (0.70–2.92) 2.51# (1.08–4.94) 1.52 (0.0–8.47) 0.00 (0.00–15.84)
Rectum, rectosigmoid junction 1.54# (1.03–2.23) 1.22 (0.56–2.32) 1.84 (0.79–3.62) 0.39 (0.01–2.19) 2.06 (0.05–11.5) 0.00 (0.00–24.49)
Thyroid 1.27# (1.03–1.55) 1.26 (0.93–1.68) 1.77# (1.24–2.45) 1.17 (0.70–1.83) 2.86# (1.05–6.22) 0.00 (0.00–9.17)
Colon 1.31 (0.99–1.7) 1.82# (1.23–2.58) 2.56# (1.67–3.75) 0.85 (0.28–1.98) 2.62 (0.54–7.65) 2.75 (0.07–15.33)
 Ascending colon 1.01 (0.44–1.99) 2.93# (1.34–5.57) 2.73 (0.89–6.37) 1.97 (0.24–7.11) 0.00 (0.00–17.3) 14.02 (0.35–78.11)
 Transverse colon 0.62 (0.08–2.24) 3.97# (1.29–9.27) 6.68# (2.17–15.59) 4.77 (0.58–17.24) 0.00 (0.00–42.6) 0.00 (0.00–126.37)
 Descending colon 1.01 (0.51–1.81) 1.41 (0.52–3.07) 1.94 (0.63–4.52) 0.00 (0.00–2.32) 3.40 (0.09–18.96) 0.00 (0.00–42.32)
 Rectum 1.59# (1.07–2.29) 1.22 (0.56–2.32) 1.83 (0.79–3.61) 0.39 (0.01–2.18) 2.06 (0.05–11.47) 0.00 (0.00–24.43)
 Other and unspecified 2.34 (0.86–5.09) 1.78 (0.22–6.45) 4.84 (1.00–14.14) 0.00 (0.00–11.74) 15.06 (0.38–83.91) 0.00 (0.00–148.5)
Female breast 1.58# (1.26–1.97) 0.78 (0.47–1.22) 1.38 (0.83–2.16) 0.48 (0.16–1.12) 1.42 (0.17–5.14) 3.60 (0.09–20.08)
Kidney parenchyma 1.75 (0.75–3.44) 1.09 (0.13–3.95) 0.00 (0.00–3.35) 2.85 (0.34–10.29) 0.00 (0.00–29.83) 0.00 (0.00–104.36)
Renal pelvis, other urinary 3.37 (0.92–8.63) 2.15 (0.05–11.98) 0.00 (0.00–13.70) 0.00 (0.00–27.27) 0.00 (0.00–117.11) 0.00 (0.00–310.28)
Pancreas 1.01 (0.46–1.92) 1.95 (0.78–4.02) 1.95 (0.53–4.98) 0.00 (0.00–3.49) 0.00 (0.00–15.72) 0.00 (0.00–42.09)
Non-Hodgkin lymphoma 1.04 (0.42–2.15) 1.06 (0.22–3.09) 0.00 (0.00–2.27) 0.00 (0.00–3.61) 0.00 (0.00–20.58) 19.38 (0.49–108.01)
Bile ducts, other biliary 1.37 (0.75–2.31) 0.72 (0.15–2.11) 1.69 (0.46–4.34) 3.45 (0.94–8.83) 0.00 (0.00–13.89) 9.79 (0.25–54.55)
Stomach 0.88 (0.62–1.22) 1.14 (0.70–1.77) 0.91 (0.42–1.73) 0.36 (0.04–1.28) 0.00 (0.00–3.44) 0.00 (0.00–10.67)
Liver 0.84 (0.42–1.51) 0.19 (0.00–1.08) 0.00 (0.00–1.19) 1.71 (0.35–5.00) 0.00 (0.00–10.68) 9.41 (0.24–52.43)
Gallbladder 0.38 (0.05–1.38) 0.92 (0.11–3.33) 1.63 (0.20–5.87) 0.00 (0.00–6.08) 0.00 (0.00–27.04) 0.00 (0.00–71.35)
Small intestine 2.63 (0.54–7.69) 2.17 (0.05–12.08) 0.00 (0.00–13.56) 0.00 (0.00–23.26) 0.00 (0.00–123.21) 0.00 (0.00–382.12)
All excluding POFT 1.26# (1.15–1.39) 1.26# (1.09–1.45) 1.64# (1.38–1.93) 0.98 (0.74–1.27) 1.31 (0.68–2.29) 2.80# (1.13–5.77)
  1. POFT: peritoneal, epithelial ovarian, and fallopian tubal; SIR: standardised incidence ratio; CI: confidence interval
  2. #significant at α = 0.05